Inspire Medical Systems, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Inspire Medical Systems, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q2 2024.
  • Inspire Medical Systems, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $9.79M.
  • Inspire Medical Systems, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $6.01M.
  • Inspire Medical Systems, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$21.2M, a 52.9% increase from 2022.
  • Inspire Medical Systems, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.9M, a 6.75% decline from 2021.
  • Inspire Medical Systems, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$42M, a 26.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $6.01M $9.79M +$21.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$15.7M -$10M +$5.42M +35.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-06
Q4 2023 -$21.2M $14.8M +$11.6M +369% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-09
Q3 2023 -$32.8M -$8.54M +$8.31M +49.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$41.1M -$12M +$2.54M +17.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$43.6M -$15.4M +$1.27M +7.61% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-06
Q4 2022 -$44.9M $3.15M +$5.54M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-09
Q3 2022 -$50.4M -$16.8M -$6.5M -62.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$43.9M -$14.5M -$1.4M -10.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$42.5M -$16.7M -$478K -2.95% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$42M -$2.39M +$5.09M +68.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-09
Q3 2021 -$47.1M -$10.3M +$38K +0.37% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$47.2M -$13.1M +$10M +43.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-01
Q1 2021 -$57.2M -$16.2M +$29K +0.18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-01
Q4 2020 -$57.2M -$7.48M +$1.6M +17.6% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-24
Q3 2020 -$58.8M -$10.4M -$2.14M -25.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$56.7M -$23.1M -$15.4M -202% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 -$41.2M -$16.2M -$7.98M -96.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 -$33.2M -$9.08M -$4.3M -90% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$28.9M -$8.25M -$3.55M -75.7% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-24
Q2 2019 -$25.4M -$7.65M -$1.79M -30.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-24
Q1 2019 -$23.6M -$8.27M -$1.77M -27.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-24
Q4 2018 -$21.8M -$4.78M -$526K -12.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-25
Q3 2018 -$21.3M -$4.69M -$671K -16.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-25
Q2 2018 -$20.6M -$5.86M -$1.1M -23.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-25
Q1 2018 -$19.5M -$6.5M -$2.02M -45.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-25
Q4 2017 -$17.5M -$4.25M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-26
Q3 2017 -$4.02M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-26
Q2 2017 -$4.76M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-26
Q1 2017 -$4.48M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.